• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant

GenapSys Nabs $90M to Commercialize Its Breakthrough Electronic Gene Sequencer

by Fred Pennic 11/20/2019 Leave a Comment

- GenapSys launches their first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital. - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size. - The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand access to genetic health insights. GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed. Now available for purchase, the device uses first-of-its-kind technology to deliver results at a fraction of the cost of legacy technologies, while still delivering highly accurate results. This latest investment round brings the company’s total funding to $166M to date. The new capital will be used to drive the commercial launch of the company’s first-generation product, grow GenapSys’ interdisciplinary team, and empower continued innovation. Accessible Sequencing Holds the Key to Innovation In 2019, 10 million people will die of cancer. And, yet, only 3 percent of cancer drugs tested in clinical trials since 2000 have been approved for patient use and not a single one offers a cure. Gene sequencing maybe the answer. By analyzing every component of our DNA, gene sequencing allows doctors and scientists to more effectively diagnose disease and develop better treatments. Beyond cancer, sequencing has the potential to supercharge everything from reproductive health to pathogen testing. But a single sequencing device typically costs up to $1M, limiting its reach and acting as a major bottleneck to advancement in healthcare. A Breakthrough in Sequencing with High Accuracy and Low Cost GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size miniaturized to the size of an iPad. It's up to 100x smaller and less expensive at under $10,000 than legacy sequencing technologies, while redefining the gold standard with over 99.9% accuracy. In other words, similar to the iPhone, sequencing will be taken to the size of a mobile device and made affordable to nearly any institution. For the $46B genomics market previously dominated by much more expensive device companies like Illumina, this could transform healthcare as we know it. Unlike many others on the market, GenapSys achieves gold standard accuracy while maintaining low costs and portability. An independent study conducted by The Jackson Laboratory, a leading global nonprofit biomedical research institution, found that GenapSys sequencers deliver consistent and excellent performance across a variety of biological samples. Recently at American Society of Human Genetics in Houston, The Jackson Laboratory presented the results of their study which found that the GenapSys sequencers are superior to optical detection methods in detecting single nucleotide mutations, a critical task used for cancer and inherited disease detection. Availability The GenapSys sequencer has been tested extensively across leading genomics labs across the nation. All studies thus far have indicated exceptional performance; published work is publicly available on BioRxiv. The GenapSys Sequencer is currently available for order in the U.S. with global sales beginning in early 2020. “We are entering a multi-decade era of genomics that will revolutionize many industries, including healthcare diagnostics, pharmaceutical discovery, personalized medicine, food testing, forensics, agriculture, biology and beyond - but until now, we’ve lacked the access necessary to realize this potential,” explained Dr. Hesaam Esfandyarpour, CEO and founder of GenapSys. “With our new sequencer, we can rapidly enable and scale genomics power to every researcher, physician, provider, and patient around the world.”

- GenapSys launches first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital.  - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size.- The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand
Read More

Wellframe Raises $20M to Accelerate Digital Care Management Solution for Care Teams

by Fred Pennic 11/19/2019 Leave a Comment

Wellframe Raises $20M to Accelerate Digital Care Management Solution for Care Teams

- Wellframe raises $20M in Series C funding to support company growth, including hiring in its Boston office, and accelerate its leadership in the Digital Health Management market.Wellframe translates evidence-based, peer-reviewed guidelines and literature into an interactive daily checklist delivered to patients through the Wellframe mobile app.The additional funding announced today will also enable Wellframe to accelerate the next phase of its Digital Health Management solutions, Digital
Read More

Heathify Raises $16M to Expand Social Determinants of Healthcare Platform for Value-Based Care

by Fred Pennic 11/04/2019 Leave a Comment

Heathify Raises $16M to Expand Social Determinants of Healthcare Platform for Value-Based Care

- NYC-based Healthify raises $16M led by SV Health to fuel the company’s growth to integrate social determinants of health in the era of value-based care. - Healthify provides an intuitive SDoH referral platform that enables collaboration between network partners.- The funding will support the company’s rapid growth as it continues to bring healthcare and social service organizations together in accountable networks.Healthify, an NYC-based company integrating the social determinants of health
Read More

FundamentalVR Lands $5.67M for VR Surgical Training Simulation Platform

by Fred Pennic 10/30/2019 Leave a Comment

FundamentalVR Inks 3-Year Partnership with Mayo Clinic to Co-Develop Surgical VR Simulations, Raises Additional $1.4M

- FundamentalVR lands $5.67M to expand its virtual reality (VR) surgical training simulation platform with haptics (the sense of touch).  - Platform is deployed with a number of medical institutions across seven countries, including Mayo Clinic and UCLA in the U.S., UCLH in the U.K., and Sana in Germany with initial training packages focused on the orthopedic surgical disciplines.FundamentalVR, developers of immersive training technology for the surgical community has raised $5.67M in Series A
Read More

Twistle Raises $16M to Expand Patient Engagement Platform

by Jasmine Pennic 10/29/2019 Leave a Comment

Twistle Raises $16M to Expand Patient Engagement Platform

- Seattle-based health IT innovator Twistle raises $16M in Series A funding from two major healthcare investors: Health Enterprise Partners (HEP) and MemorialCare Innovation Fund (MCIF). - The funding investors are healthcare-centric: MCIF is a strategic healthcare investment fund wholly-owned by a healthcare system and HEP is a private equity firm that invests exclusively in healthcare services and IT companies.- The funding will accelerate the delivery of personalized care guidance through
Read More

InsureTech Chatbot Platform Sensely Raises $15M to Modernize Member Experience

by Fred Pennic 10/28/2019 Leave a Comment

InsureTech Chatbot Platform Sensely Raises $15M to Modernize Member Experience

- Digital health and InsureTech chatbot platform Sensely announced it has raised $15M in funding led by Aflac Corporate Ventures, the venture arm of Aflac Inc. - The funding brings expanded commercial pathways to Sensely, with markets serving over 60 million members and representing over $200MM in annual recurring revenue opportunities.   Today, at HLTH 2019, Sensely, a San Francisco, CA-based digital health and InsureTech platform that modernizes member experience while lowering costs,
Read More

Amazon Acquires Health Navigator to Become Part of Amazon Care Services

by Fred Pennic 10/24/2019 Leave a Comment

Amazon Acquires Health Navigator to Become Part of Amazon Care Group Services

- Amazon acquires Chicago-based Health Navigator platform, a comprehensive clinical vocabulary, and decision-support system.- The announcement marks Amazon’s second acquisition in the healthcare space after acquiring online pharmacy market PillPack for $750M last year. - CNBC confirms Health Navigator will not renew existing contracts with their customers moving forward and will become part of Amazon Care, it's pilot healthcare service program for employees.Amazon has acquired Health Navigator,
Read More

AVIA Lands $22M to Expand Healthcare Innovation Network to New Markets

by Fred Pennic 10/23/2019 Leave a Comment

AVIA Lands $22M to Expand Healthcare Innovation Network to New Markets

- AVIA raises $22M to expand its leading healthcare innovation network to expand its service offerings and reach new markets. - Specifically, AVIA will tap into the new funds to grow its offerings in areas including consumerism, population health, and risk management, and to reach new markets such as pediatric hospitals and payers.- Members of the AVIA Innovator Network access unique insights, participate in collaborative strategic initiatives, and engage in consulting services to increase speed
Read More

XLerateHealth Awarded $1.7M Grants to Fuel Healthcare Innovation in Under-Resourced States

by Fred Pennic 10/22/2019 Leave a Comment

XLerateHealth Accelerator Unveils Its Sixth Class of 10 Digital Health Startups

- XLerateHealth (XLH) has been awarded a total of $1.7M in grants to continue building the XLerator Network and support academic healthcare innovation across the Southeast. - The continuation of the grant secures a second year of funding for XLH and its partners to build on foundational assessment and planning work completed in year one.XLerateHealth (XLH), a Louisville, KY-based healthcare accelerator has been awarded grants totaling $1.7M to continue building the XLerator Network and support
Read More

Medinas Raises $5M to Expand Pre-Owned Medical Equipment Marketplace

by Jasmine Pennic 10/22/2019 Leave a Comment

Medinas Raises $5M to Expand Asset Management Platform for Hospitals

- Medinas close $5M seed funding round led by NFX to expand pre-owned medical equipment marketplace and asset management software for hospitals. - Pre-owned medical equipment marketplace and asset management software has helped hospitals reduce waste and save over $50M in sales equivalency by making equipment remarketing fast, easy and safe.- The Medinas Price Book utilizes over 9 million data points to provide estimated equipment values for the $156 billion healthcare equipment market in the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 127
  • Go to page 128
  • Go to page 129
  • Go to page 130
  • Go to page 131
  • Interim pages omitted …
  • Go to page 268
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |